(Q48630222)

13 February 2018

title

Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia. (English)

1 reference

13 February 2018

0 references

0 references

1

1 reference

13 February 2018

Kaj Blennow

series ordinal

5

object named as

Kaj Blennow

1 reference

13 February 2018

Carl-Gerhard Gottfries

series ordinal

3

object named as

Carl-Gerhard Gottfries

1 reference

13 February 2018

Pia Davidsson

2

1 reference

13 February 2018

Jan-Eric Månsson

series ordinal

4

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

published in

Schizophrenia Research

1 reference

13 February 2018

volume

55

1 reference

13 February 2018

issue

1-2

1 reference

13 February 2018

page(s)

83-88

1 reference

13 February 2018

Neurobiological investigations in cingulate cortex of schizophrenic brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Alterations of neural circuitry within layer II of anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Synaptic degeneration in thalamus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Recent advances in the neuropathology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Fat consumption and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Neurochemical dissection of synaptic pathology in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Defining the course of brain structural change and plasticity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Regional brain volume change over the life-time course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Fatty acids and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Abnormal reinnervation as a basis for schizophrenia: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

A procedure for the quantitative isolation of brain gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

10.1016/S0920-9964(01)00197-9

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018